Ameriprise’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-188,099
Closed -$952K 4089
2025
Q3
$952K Sell
188,099
-1,012
-0.5% -$4.47K ﹤0.01% 3388
2025
Q2
$762K Hold
189,111
﹤0.01% 3376
2025
Q1
$516K Sell
189,111
-91,655
-33% -$329K ﹤0.01% 3473
2024
Q4
$1.19M Sell
280,766
-596
-0.2% -$2.27K ﹤0.01% 3168
2024
Q3
$827K Buy
+281,362
New +$896K ﹤0.01% 3292

Other funds holding SRTA

Ameriprise's SRTA Position: Q4 2025 in Review

Ameriprise sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 188,099 shares — an estimated $952K sold.

Ameriprise first reported a position in SRTA in Q3 2024 and held it in 5 quarters. The position peaked at $1.19M in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • Ameriprise reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 188,099 Strata Critical Medical Inc shares in Q4 2025, an estimated $952K.
  • Ameriprise first reported a position in Strata Critical Medical Inc in Q3 2024 and held it in 5 quarters.
  • Ameriprise's Strata Critical Medical Inc position peaked at $1.19M in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.